Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Review

Published on 19 May 2025

Decoding glycosylation in cardiovascular diseases: mechanisms, biomarkers, and therapeutic opportunities

in Cardiovascular and Smooth Muscle Pharmacology

Gang Li
Kaidi Ren
Yage Jin
Yang Yang
Yi Luan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570158

3,651 views
1 citation

Review

Published on 16 May 2025

Global research trends and hotspots in aspirin studies (2014–2024): a bibliometric perspective

in Cardiovascular and Smooth Muscle Pharmacology

Ning Sun
Bochao Jia
Rui Wei
Taiwei Lou
Zirong Li
Xiaowei Nie
Xujie Wang
Wenxiao Yu
Qiuyan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1513318

3,246 views

Review

Published on 15 May 2025

Investigation of the mechanism of hypertension caused by BTKi in the treatment of hematologic diseases

in Cardiovascular and Smooth Muscle Pharmacology

Jiayi Xu
Junling Lin
Haojian Gan
Qingjian He
WenJuan Wang
Yuanhua Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585061

3,447 views

Editorial

Published on 15 May 2025

Editorial: Emerging trends in cardiac and skeletal muscle pharmacotherapy

in Cardiovascular and Smooth Muscle Pharmacology

Young Hoon Son
Ivan Vechetti
Dawn Katrina Coletta

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1619972

1,193 views

Mini Review

Published on 14 May 2025

The role of statins in the regulation of breast and colorectal cancer and future directions

in Cardiovascular and Smooth Muscle Pharmacology

Yexing Dang
Yu Zhang
Zhihao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578345

3,873 views
2 citations

Review

Published on 12 May 2025

Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation

in Cardiovascular and Smooth Muscle Pharmacology

Xue-Xue Zhu
Chen-Yang Zhao
Qing-Bo Lu
Ao-Yuan Zhang
Xin-Yu Meng
Jia-Bao Su
Guo Chen
An-Jing Xu
Hai-Jian Sun
Xiao-Wei Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1510275

2,690 views

Mini Review

Published on 08 May 2025

Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy

in Cardiovascular and Smooth Muscle Pharmacology

Jia-Hui Liu
Kun-Yao Liu
Xiang Zhao
Xin Zhou
Yichuan Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578157

3,165 views
1 citation

Original Research

Published on 30 Apr 2025

Pulmonary artery-targeted low-dose metformin-loaded nanocapsules safely improve pulmonary arterial hypertension in rats

in Cardiovascular and Smooth Muscle Pharmacology

Ayako Chida-Nagai
Naoki Masaki
Hiroki Sato
Tatsuya Kato
Emi Takakuwa
Yoshihiro Matsuno
Atsushi Manabe
Atsuhito Takeda

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577570

2,796 views
1 citation

Review

Published on 30 Apr 2025

Macrophage-driven exosomes regulate the progression of cardiovascular disease

in Cardiovascular and Smooth Muscle Pharmacology

Liao Qi
De-Zhu Luo
HuLi Li
JianWen Yan
WenJie He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563800

5,180 views
5 citations

Original Research

Published on 29 Apr 2025

IGFBP5 mediates the therapeutic effect of isoliquiritigenin in myocardial ischemia-reperfusion injury via AKT/GLUT4 regulated insulin resistance

in Cardiovascular and Smooth Muscle Pharmacology

Jue Bai
Si-Yuan Yang
Shao-Mei Yu
Ying Cao
Chang-Han Ma
Xuan-Yi Hu
Xiong Chen
Ying-Nan Song
Hong-Jin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1544869

2,523 views

Original Research

Published on 28 Apr 2025

Major risk factors underlying the development of metabolic syndrome in vitamin D-deficient rats

in Cardiovascular and Smooth Muscle Pharmacology

Fatemah O. Kamel
S. K. Mahjoub
M. A. A. Sattar Ahmad
Maha H. Jamal
Duaa M. Bakhshwin
Abdulhadi S. Burzangi
Soad Shaker
Rania Magadmi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573332

1,873 views

Review

Published on 28 Apr 2025

Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy

in Cardiovascular and Smooth Muscle Pharmacology

Feng Liu
Haipeng Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1583267

3,305 views
2 citations

Editorial

Published on 28 Apr 2025

Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings

in Cardiovascular and Smooth Muscle Pharmacology

Maria del Carmen Asensio-Lopez
Paolo Severino
Antonio Lax

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1607362

1,617 views

Review

Published on 25 Apr 2025

Comprehensive evaluation of non-coding RNA-mediated autophagy regulation in myocardial ischemia-reperfusion injury

in Cardiovascular and Smooth Muscle Pharmacology

Zhongyang Song
Chang Suo
Yongqi Liu
Ling Jin
Xiaodong Xie
Jian Liu
Bo Yu
Yanzhen Wang
Zhiming Zhang
Dingxiong Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1581341

2,627 views
1 citation

Original Research

Published on 25 Apr 2025

Thrombotic adverse events associated with TNF-alpha blockers: a real-world pharmacovigilance analysis of the FAERS database

in Cardiovascular and Smooth Muscle Pharmacology

Lijuan Song
Nan Yang
Xinglong Xing
Yicong Zhao
Jingkai Di

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1512806

3,489 views
1 citation

Original Research

Published on 23 Apr 2025

Clusterin ameliorates diabetic atherosclerosis by suppressing macrophage pyroptosis and activation

in Cardiovascular and Smooth Muscle Pharmacology

Lingling Xuan
Lulu Ren
Xiaoxu Kang
Rui Chang
Wen Zhang
Lili Gong
Lihong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536132

2,917 views
1 citation

Original Research

Published on 17 Apr 2025

α-Mangostin prevents diabetic cardiomyopathy by inhibiting oxidative damage and lipotoxicity through the AKT–FOXO1–CD36 pathway

in Cardiovascular and Smooth Muscle Pharmacology

Xue Bai
Ziqian Zhang
Miao Zhang
Jiaojiao Xu
Keting Dong
Qian Du
Lei Chen
Ping Ma
Jianhong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1566311

4,393 views
3 citations

Review

Published on 17 Apr 2025

NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals

in Cardiovascular and Smooth Muscle Pharmacology

Xiao-Peng Zhao
Lian Duan
Qian-Ru Zhao
Xing Lv
Nai-Yuan Tian
Sheng-Lei Yang
Kun Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1567312

2,953 views
3 citations

Mini Review

Published on 15 Apr 2025

The functional significance of vascular DNA hypermethylation in atherosclerosis: a historical perspective

in Cardiovascular and Smooth Muscle Pharmacology

Silvio Zaina

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562674

2,233 views

Original Research

Published on 14 Apr 2025

Cardiac protection of wogonin in mice with pulmonary fibrosis by regulating Sirt1/ γ-H2AX pathway

in Cardiovascular and Smooth Muscle Pharmacology

Libo Wang
Fei Lin
Runran Miao
Tianhao Zhao
Yuan Liu
Lin Yang
Min Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551141

2,803 views
2 citations

Review

Published on 10 Apr 2025

Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease

in Cardiovascular and Smooth Muscle Pharmacology

Qingqing Liu
Peizhong Liu
Chuangpeng Li
Zhen Zhao
Dawei Wang
Qing Liu
Huawei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499786

2,654 views

Review

Published on 04 Apr 2025

Acacetin as a natural cardiovascular therapeutic: mechanisms and preclinical evidence

in Cardiovascular and Smooth Muscle Pharmacology

Zihe Zhou
Tao Li
Helin Qin
Xinyu Wang
Shanshan He
Zhongcai Fan
Qiang Ye
Yanfei Du

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1493981

6,392 views
4 citations

Review

Published on 02 Apr 2025

Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology

in Cardiovascular and Smooth Muscle Pharmacology

Luwen Zhang
Wei Wang
Xincan Liu
Kuipo Yan
Qiang Li
Ming Li
Chunying Li
Yanxin Li
Lei Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499060

2,624 views
1 citation

Original Research

Published on 02 Apr 2025

LncRNA MEG3 exacerbates diabetic cardiomyopathy via activating pyroptosis signaling pathway

in Cardiovascular and Smooth Muscle Pharmacology

Shengnan Zhuo
Yifeng Liu
Siyuan Wang
Zhuoling Chen
Xuran Shi
Yangjunna Zhang
Dengfeng Xu
Jingjin Hu
Yin Wang
Xuefeng Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538059

3,013 views
2 citations

1,408 articles

articles

Decoding glycosylation in cardiovascular diseases: mechanisms, biomarkers, and therapeutic opportunities

Global research trends and hotspots in aspirin studies (2014–2024): a bibliometric perspective

Investigation of the mechanism of hypertension caused by BTKi in the treatment of hematologic diseases

Editorial: Emerging trends in cardiac and skeletal muscle pharmacotherapy

The role of statins in the regulation of breast and colorectal cancer and future directions

Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation

Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy

Pulmonary artery-targeted low-dose metformin-loaded nanocapsules safely improve pulmonary arterial hypertension in rats

Macrophage-driven exosomes regulate the progression of cardiovascular disease

IGFBP5 mediates the therapeutic effect of isoliquiritigenin in myocardial ischemia-reperfusion injury via AKT/GLUT4 regulated insulin resistance

Major risk factors underlying the development of metabolic syndrome in vitamin D-deficient rats

Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy

Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings

Comprehensive evaluation of non-coding RNA-mediated autophagy regulation in myocardial ischemia-reperfusion injury

Thrombotic adverse events associated with TNF-alpha blockers: a real-world pharmacovigilance analysis of the FAERS database

Clusterin ameliorates diabetic atherosclerosis by suppressing macrophage pyroptosis and activation

α-Mangostin prevents diabetic cardiomyopathy by inhibiting oxidative damage and lipotoxicity through the AKT–FOXO1–CD36 pathway

NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals

The functional significance of vascular DNA hypermethylation in atherosclerosis: a historical perspective

Cardiac protection of wogonin in mice with pulmonary fibrosis by regulating Sirt1/ γ-H2AX pathway

Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease

Acacetin as a natural cardiovascular therapeutic: mechanisms and preclinical evidence

Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology

LncRNA MEG3 exacerbates diabetic cardiomyopathy via activating pyroptosis signaling pathway